Airways remodelling in asthma

Pulmonary Pharmacology and Therapeutics

Volumn 11, Issue 5-6, 1998, Pages 359-367

  Vignola, A M ^a   Chanez, P ^b   Siena, L ^a   Chiappara, G ^a   Bonsignore, G ^a   Bousquet, J ^b  

^a CNR   (Italy)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GROWTH FACTOR; RANTES; STEROID;

AIRWAY OBSTRUCTION; ASTHMA; BASEMENT MEMBRANE; CONFERENCE PAPER; EOSINOPHIL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN TISSUE; HYPERPLASIA; HYPERTROPHY; MAST CELL; MUCUS GLAND; MYOFIBROBLAST; PARENCHYMA; PRIORITY JOURNAL; SMOOTH MUSCLE;

EID: 0032193644     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1999.0163     Document Type: Conference Paper

References (148)

1. 1. Kamm R D, Drazen J M. Airway hyperresponsiveness and airway wall thickening in asthma. A quantitative approach [editorial; comment]. Am Rev Respir Dis 1992; 145: 1249-1250.
2. 2. Boulet L, Belanger M, Carrier G. Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. Am J Respir Crit Care Med 1995; 152: 865-871.
3. 3. Dunnill M, Massarella G, Anderson J. Comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 1969; 24: 176-179.
4. 4. Hossain S, BE H. Hyperplasia of bronchial muscle in chronic bronchitis. J Path 1970; 101: 171-184.
5. 5. Saetta M, Di-Stefano A, Rosina C, Thiene G, Fabbri L M. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143: 138-143.
6. 6. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993; 147: 405-410.
7. 7. Hogg J C. Pathology of asthma. J Allergy Clin Immunol 1993; 92: 1-5.
8. 8. Sobonya R E. Quantitative structural alterations in long-standing allergic asthma. Am Rev Respir Dis 1984; 130: 289-292.
9. 9. Ebina M, Yaegashi H, Takahashi T, Motomiya M, Tanemura M. Distribution of smooth muscles along the bronchial tree. A morphometric study of ordinary autopsy lungs. Am Rev Respir Dis 1990; 141: 1322-1326.
10. 10. Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 1993; 148: 720-726.
11. 11. Halayko A J, Stephens N L. Potential role for phenotypic modulation of bronchial smooth muscle cells in chronic asthma. Can J Physiol Pharmacol 1994; 72: 1448-1457.
12. 12. Postma D, Koeter G H, Sluiter H J. Pathophysiology of airway hyperresponsiveness. In: S W, D S, eds. Airway Responsiveness and Atopy in the Development of Chronic Lung Disease. New York: Raven Press Ltd, 1989: 21-71.
13. 13. Noveral J P, Grunstein M M. Role and mechanism of thromboxane-induced proliferation of cultured airway smooth muscle cells. Am J Physiol 1992; 263: L555-L561.
14. 14. De S, Zelazny E T, Souhrada J F, Souhrada M. IL-1 β and IL-6 induce hyperplasia and hypertrophy of cultured guinea pig airway smooth muscle cells. J Appl Physiol 1995; 78: 1555-1563.
15. 15. Noveral J P, Rosenberg S M, Anbar R A, Pawlowski N A, Grunstein N M. Role of endothelin-1 in regulating proliferation of cultured rabbit airway smooth muscle cells. Am J Physiol 1992; 263: L317-L324.
16. 16. Stewart A G, Grigoriadis G, Harris T. Mitogenic actions of endothelin-1 and epidermal growth factor in cultured airway smooth muscle. Clin Exp Pharmacol Physiol 1994; 21: 277-285.
17. 17. Shiels I A, Bowler S D, Taylor S M. Airway smooth muscle proliferation in asthma: the potential of vascular leakage to contribute to pathogenesis. Med Hypotheses 1995; 45: 37-40.
18. 18. Mitchell R W, Ruhlmann E, Magnussen H, Leff A R, Rabe K F. Passive sensitizations of human bronchi augments smooth muscle shortening velocity and capacity. Am J Physiol 1994; 267: L218-L222.
19. 19. James A L, Pare P D, Hogg J C. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989; 139: 242-246.
20. 20. Wiggs B R, Bosken C, Pare P D, James A, Hogg J C. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease [see comments]. Am Rev Respir Dis 1992; 145: 1251-1258.
21. 21. Dunnill M. The pathology of asthma with special references of changes in the bronchial mucosa. J Clin Pathol 1960; 13: 27-33.
22. 22. Cluroe A, Holloway L, Thomson K, Purdie G, Beasley R. Bronchial gland duct ectasia in fatal bronchial asthma: association with interstitial emphysema. J Clin Pathol 1989; 42: 1026-1031.
23. 23. Cluroe A D, Beasley R, Lorimer S, Holloway L. The relationship between pulmonary interstitial emphysema and clinical features in fatal asthma. J Asthma 1994; 31: 65-69.
24. 24. Paganin F, Trussard V, Seneterre E, Chanez P, Giron J, Godard P, Senac J P, Michel F B, Bousquet J. Chest radiography and high resolution computed tomography of the lungs in asthma. Am Rev Respir Dis 1992; 146: 1084-1087.
25. 25. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992; 101: 916-921.
26. 26. Reid L M. The presence or absence of bronchial mucus in fatal asthma. J Allergy Clin Immunol 1987; 80: 415-416.
27. 27. Sheehan J K, Richardson P S, Fung D C, Howard M, Thornton D J. Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus. Am J Respir Cell Mol Biol 1995; 13: 748-756.
28. 28. Pavia D, Bateman J R, Sheahan N F, Agnew J E, Clarke S W. Tracheobronchial mucociliary clearance in asthma: impairment during remission. Thorax 1985; 40: 171-175.
29. 29. Cutz E, Levison H, Cooper D M. Ultrastructure of airways in children with asthma. Histopathology 1978; 2: 407-421.
30. 30. Roche W R, Beasley R, Williams J H, Holgate S T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1: 520-524.
31. 31. Brewster C E, Howarth P H, Djukanovic R, Wilson J, Holgate S T, Roche W R. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990; 3: 507-511.
32. 32. Jeffery P K, Wardlow A J, Nelson F C, Collins J V, Kay A B. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140: 1745-1753.
33. 33. Saetta M, Maestrelli P, di Stefano A, De-Marzo N, Milani G F, Pivirotto F, Mapp C E, Fabbri L M. Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma. Am Rev Respir Dis 1992; 145: 169-174.
34. 34. Chetta A, Foresi A, del Donno M, Bertorelli G, Pesci A, Olivieri D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997; 111: 852-857.
35. 35. Lacoste J Y, Bousquet J, Chanez P, Van-Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, Michel F B. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993; 92: 537-548.
36. 36. Ollerenshaw S L, Woolcock A J. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am Rev Respir Dis 1992; 145: 922-927.
37. 1. Am J Respir Crit Care Med 1997; 155: 852-857.
38. 38. Battegay E J. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 1995; 73: 333-346.
39. 39. Kuwano K, Bosken C H, Pare P D, Bai T R, Wiggs B R, Hogg J C. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148: 1220-1225.
40. 40. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J. Cell adhesion, cell junctions, and the extracellular matrix. In: Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J, eds. Molecular Biology of the Cell, 2nd edn. New York: Garland Publishing Co, 1989: 792-834.
41. 41. Raghow R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 1994; 8: 823-831.
42. 42. McGowan S E. Extracellular matrix and the regulation of lung development and repair. FASEB J 1992; 6: 2895-2904.
43. 43. van der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991; 5: 2814-2823.
44. 44. Bousquet J, Lacoste J, Chanez P, Vic P, Godard P, Michel F. Bronchial elastic fibers in normal subjects and asthmatic patients. Am J Respir Crit Care Med 1996; 153: 1648-1653.
45. 45. Godfrey R W, Lorimer S, Majumdar S, Adelroth E, Johnston P W, Rogers A V, Johansson S A, Jeffery P K. Airway and lung elastic fibre is not required in asthma nor in asthmatics following corticosteroid treatment. Eur Respir J 1995; 8: 922-927.
46. 46. Hardingham T E, Fosang A J. Proteoglycans: many forms and many functions. FASEB J 1992; 6: 861-870.
47. 47. Mosher D, Sottile J, Wu C, McDonald J. Assembly of extracellular matrix. Curr Opin Cell Biol 1992; 4: 810-818.
48. 48. Matrisian L M. The matrix-degrading metalloproteinases. Bioessays 1992; 14: 455-463.
49. 49. O'Connor C M, FitzGerald M X. Matrix metalloproteases and lung disease. Thorax 1994; 49: 602-609.
50. 50. Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M, Isoyama S, Tanno Y, Tamura G, Yamauchi K, Nagura H, Shirato K. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997; 16: 212-219.
51. 51. Mautino G, Oliver N, Chanez P, Bousquet J, Capony F. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 1997; 17: 583-591.
52. 52. Messner J, Peters G, Bennet W. Causes of death and pathologic findings in 304 cases of bronchial asthma. Dis Chest 1960; 38: 616-624.
53. 53. Ohno I, Lea R G, Flanders K C, Clark D A, Banwatt D, Dolovich J, Denburg J, Harley C B, Gauldie J, Jordana M. Eisinophils in chronically inflamed human upper airway tissues express transforming growth factor β 1 gene (TGF-β 1). J Clin Invest 1992; 89: 1662-1668.
54. 54. Walz T M, Nishikawa B K, Malm C, Wasteson A. Production of transforming growth factor alpha by normal human blood eosinophils. Leukemia 1993; 7: 1531-1537.
55. 55. Lungarella G, Menegazzi R, Gardi C, Spessotto P, de-Santi M M, Bertoncin P, Patriarca P, Calzoni P, Zabucchi G. Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. Arch Biochem Biophys 1992; 292: 128-135.
56. 56. Pincus S H, Ramesh K S, Wyler D J. Eosinophils stimulate fibroblast DNA synthesis. Blood 1987; 70: 572-574.
57. 57. Hall F C, Walport M J. Hypereosinophilic syndromes: association with vasculitis, fibrosis and autoimmunity [editorial; comment]. Clin Exp Allergy 1993; 23: 542-547.
58. 58. Schlick W. Current issues in the assessment of interstitial lung disease. Monaldi Arch Chest Dis 1993; 48: 237-244.
59. 59. Ottesen E A, Nutman T B. Tropical pulmonary eosinophilia. Annu Rev Med 1992; 43: 417-424.
60. 60. Noguchi H, Kephart G M, Colby T V, Gleich G J. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol 1992; 140: 521-528.
61. 61. Kawanami O, Ferrans V J, Fulmer J D, Crystal R G. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest 1979; 40: 717-734.
62. 62. Jordana M. Mast cells and fibrosis - who's on first? Am J Respir Cell Mol Biol 1993; 8: 7-8.
63. 63. Chanez P, Lacoste J Y, Guillot B, Giron J, Barneon G, Enander I, Godard P, Michel F B, Bousquet J. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung. Am Rev Respir Dis 1993; 147: 1497-1502.
64. 64. Ruoss S J, Hartmann T, Caughey G H. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991; 88: 493-499.
65. 65. Nagata Y, Matsumura F, Motoyoshi H, Yamasaki H, Fukuda K, Tanaka S. Secretion of byaluronic acid from synovial fibroblasts is enhanced by histamine: a newly observed metabolic effect of histamine. J Lab Clin Med 1992; 120: 707-712.
66. 66. Thompson H L, Burbelo P D, Gabriel G, Yamada Y, Metcalfe D D. Murine mast cells synthesize basement membrane components. A potential role in early fibrosis. J Clin Invest 1991; 87: 619-623.
67. 67. Kovacs E, DiPetro L. Fibrogenic cytokines and connective tissue production. FASEB J 1994; 8: 854-861.
68. 68. Chapman H A, Allen C L, Stone O L. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am Rev Respir Dis 1986; 133: 437-443.
69. 69. Lyberg T, Nakstad B, Hetland O, Boye N P. Procoagulant (thromboplastin) activity in human bronchoalveolar lavage fluids is derived from alveolar macrophages. Eur Respir J 1990; 3: 61-67.
70. 70. Piguet P F, Ribaux C, Karpuz V, Grau G E, Kapanci Y. Expression and localization of tumor necrosis factor-α and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol 1993; 143: 651-655.
71. 71. Standiford T J, Rolfe M W, Kunkel S L, Lynch J D, Burdick M D, Gilbert A R, Orringer M B, Whyte R I, Stricter R M. Macrophage inflammatory protein-1 α expression in interstitial lung disease. J Immunol 1993; 151: 2852-2863.
72. 72. Antoniades H N, Bravo M A, Avila R E, Galanopoulos T, Neville-Golden J, Maxwell M, Selman M. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 1990; 86: 1055-1064.
73. 73. Marinelli W A, Polunovsky V A, Harmon K R, Bitterman P B. Role of platelet-derived growth factor in pulmonary fibrosis [comment]. Am J Respir Cell Mol Biol 1991; 5: 503-504.
74. 74. Vignaud J M, Allam M, Martinet N, Pech M, Plenat F, Martinet Y. Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene [see comments]. Am J Respir Cell Mol Biol 1991; 5: 531-538.
75. 75. Shaw R J, Benedict S H, Clark R A, King T Jr. Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage (PDGF(B) gene activation and up-regulation by interferon γ. Am Rev Respir Dis 1991; 143: 167-173.
76. 76. Vignola A, Chanez P, Chiappara G, Merendino A, Zinnanti E, Bousquet J, Bonsignore G. Release of transforming growth factor-β and fibronectin by alveolar macrophages in airway diseases. Clin Exp Immunol 1996; 106: 114-119.
77. 77. Taylor I K, Sorooshian M, Wangoo A, Haynes A R, Kotecha S, Mitchell D M, Shaw R J. Platelet-derived growth factor-β mRNA in human alveolar macrophages in vivo in asthma. Eur Respir J 1994; 7: 1966-1972.
78. 78. Sunderkötter C, Steinbrink K, Goebeler M, Bhardawaj R, Sorg C. Macrophages and angiogenesis. J Leukocyte Biol 1994; 55: 410-422.
79. 79. Shaw R J. The role of lung macrophages at the interface between chronic inflammation and fibrosis. Respir Med 1991; 85: 267-273.
80. 80. Sheppard M N, Harrison N K. New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis. Thorax 1992; 47: 1064-1074.
81. 81. Gizycki M J, Adelroth E, Rogers A V, O'Byrne P M, Jeffrey P K. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 1997; 16: 664-673.
82. 82. Zhang S, Mohammed Q, Burbidge A, Morland C, Roche W. Cell culture from bronchial supepithelial myofibroblasts enhance eosinophil survival in vitro. Eur Respir J 1996; 9: 1839-1846.
83. 83. Zhang H Y, Gharaee-Kermani M, Zhang K, Karmiol S, Phan S H. Lung fibroblast a smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol 1996; 148: 527-537.
84. 84. Leslie K O, Mitchell J, Low R. Lung myofibroblasts. Cell Motil Cytoskel 1992; 22: 92-98.
85. 85. Kuhn C, McDonald J A. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 1991; 138: 1257-1265.
86. 86. Gabbrielli S, di Lollo S, Stanflin N, Romagnoli P. Myofibroblast and elastic and collagen fiber hyperplasia in the bronchial mucosa: a possible basis for the progressive irreversibility of airway obstruction in chronic asthma. Pathologica 1994; 86: 157-160.
87. 87. Border W, Noble N. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
88. 88. Brach M A, Sott C, Kiehntopf M, Herrmann F. Expression of the transforming growth factor-α gene by human eosinophils is regulated by interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor. Eur J Immunol 1994; 24: 646-650.
89. 89. Elovic A, Wong D T, Weller P F, Matossian K, Galli S J. Expression of transforming growth factors-α and β 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 1994; 93: 864-869.
90. 90. Kadin M, Butmarc J, Elovic A, Wong D. Eosinophils are the major source of transforming growth factor-β in nodular sclerosing Hodgkin's disease. Am J Pathol 1993; 142: 11-16.
91. 91. Magnan A, Frachon I, Rain B, Peuchmaur M, Monti G, Lenot B, Fattal M, Simmoneau G, Galanaud P, Emile D. Transforming growth factor β in normal human lung: preferential location in bronchial epithelial cells. Thorax 1994; 49: 789-792.
92. 92. Ross R. Platelet-derived growth factor. Lancet 1989; 1: 1179-1182.
93. 93. Heldin C H. Structural and functional studies on platelet-derived growth factor. Embo J 1992; 11: 4251-4259.
94. 94. Grant M B, Khaw P T, Schultz G S, Adams J L, Shimizu R W. Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-β on corneal cell chemotaxis. Invest Opthalmol Vis Sci 1992; 33: 3292-3301.
95. 95. Kumar R K, O'Grady R, Li W, Rajkovic I. Secretion of epidermal growth factor-like molecular species by lung parenchymal macrophages: induction by interferon-γ. Growth Factors 1993; 9: 223-230.
96. 96. Kumar R, Velan G, O'Grady R. Epidermal growth factor-like activity in bronchoalveolar lavage fluid in experimental silicosis. Growth Factors 1994; 10: 163-170.
97. 97. Demetri G D, Griffin J D. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78: 2791-2808.
98. 98. Vignola A M, Chanez P, Chiappara G, Merendino A M, Pace E, Rizzo A, La Rocca A M, Bellia V, Bonsignore G, Bousquet J. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 591-599.
99. 99. Aubert J D, Dalal B I, Bai T R, Roberts C R, Hayashi S, Hogg J C. Transforming growth factor β gene expression in human airways. Thorax 1994; 49: 225-232.
100. 100. Chanez P, Vignola M, Steinger R, Vic P, Michel F, Bousquet J. Platelet-derived growth factor in asthma. Allergy 1995; 50: 878-883.
101. 101. Aubert J D, Hayashi S, Hards J, Bai T R, Pare P D, Hogg J C. Platelet-derived growth factor and its receptor in lungs from patients with asthma and chronic airflow obstruction. Am J Physiol 1994; 266: L655-L663.
102. 102. Ohno K, Ammann P, Fasciati R, Maier P. Transforming growth factor β 1 preferentially induces apoptotic cell death in rat hepatocytes cultured under pericentral-equivalent conditions. Toxicol Appl Pharmacol 1995; 132: 227-236.
103. 103. Lama M. Pulmonary fibrosis: human and experimental disease. Connective tissue in health and disease. ?? 1990; 1: 123-188.
104. 104. Laitinen L A, Laitinen A. Remodelling of asthmatic airways by glucocorticosteroids. J Allergy Clin Immunol 1996; 97: 153-158.
105. 105. Jeffery P K, Godfrey R W, Adelroth E, Nelson F, Rogers A, Johansson S A. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir 1992; 145: 890-899.
106. 106. Lundgren R, Soderberg M, Horstedt P, Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and ten years of treatment with inhaled steroids. Eur Respir J 1988; 1: 883-889.
107. 107. Saetta M, Maestrelli P, Turato G, Mapp C E, Milani G, Pivirotto F, Fabbri L M, Di-Stefano A. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med 1995; 151: 489-494.
108. 108. Trigg C J, Manolitsas N D, Wang J, Calderon M A, McAulay A, Jordan S E, Herdman M J, Jhalli N, Duddle J M, Hamilton S A. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994; 150: 17-22.
109. 109. Olivieri D, Chetta A, del Donno M, Bertorelli G, Casalini A, Pesci A, Testi R, Foresi A. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997; 155: 1864-1871.
110. 110. Padrid P A, Cozzi P, Leff A R. Cyclosporine A inhibits airway reactivity and remodeling after chronic antigen challenge in cats. Am J Respir Crit Care Med 1996; 154: 1812-1818.
111. 111. Brown P J, Greville H W, Finucane K E. Asthma and irreversible airflow obstruction. Thorax 1984; 39: 131-136.
112. 112. Greenough A, Loftus B G, Pool J, Price J F. Abnormalities of lung mechanics in young asthmatic children. Thorax 1987; 42: 500-505.
113. 113. Connolly M J, Avery A J, Walters E H, Hendrick D J. The relationship between bronchial responsiveness to methacholine and bronchial responsiveness to histamine in asthmatic subjects. Pulm Pharmacol 1999; 1: 53-58.
114. 114. Boulet L P, Turcotte H, Brochu A. Persistence of airway obstruction and hyperresponsiveness in subjects with astham remission. Chest 1994; 105: 1024-1031.
115. 115. Cade J, Pain M. Pulmonary function during clinical remission of asthma. How reversible is asthma? Aust NZ J Med 1973; 3: 545-551.
116. 116. Ferguson A C. Persisting airway obstruction in asymptomatic children with asthma with normal peak expiratory flow rates. J Allergy Clin Immunol 1988; 82: 19-22.
117. 117. Kelly W J, Hudson I, Raven J, Phelan P D, Pain M C, Olinsky A. Childhood asthma and adult lung function. Am Rev Respir Dis 1988; 138: 26-30.
118. 118. Blackball M. Ventilatory function in subjects with childhood asthma that have become symptom free. Arch Dis Child 1970; 45: 363-366.
119. 119. Wagner E M, Liu M C, Weinmann G G, Permutt S, Bleecker E R. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 1990; 141: 584-588.
120. 120. van Essen-Zandvliet E E, Hughes M D, Waalkens H J, Duiverman E J, Kerrebijn K F. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group. Eur Respir J 1994; 7: 63-68.
121. 121. Peat J K, Woolcock A J, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70: 171-179.
122. 122. Burrows B, Halonen M, Lebowitz M D, Knudson R J, Barbee R A. The relationship of serum immunoglobulin E, allergy skin tests, and smoking to respiratory disorders. J Allergy Clin Immunol 1982; 70: 199-204.
123. 123. Schachter E N, Doyle C A, Beck G J. A prospective study of asthma in a rural community. Chest 1984; 85: 623-630.
124. 124. Bousquet J, Godard P, Michel F. Asthma in adults. In: Michel F, Bousquet J, Godard P, eds. Highlights in Asthmology. Munich, Germany: Springer Verlag, 1987: 394-398.
125. 125. van Schayck C P, Dompeling E, van Herwaarden C L, Wever A M, van Weel C. Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma. Am Rev Respir Dis 1991; 144: 1297-1301.
126. 126. Almind M, Viskum K, Evald T, Dirksen A, Kok-Jensen A. A seven-year follow-up study of 343 adults with bronchial asthma. Dan Med Bull 1992; 39: 561-565.
127. 127. Ulrik C S, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47: 14-18.
128. 128. van Schayck C P, Folgering H, den Otter J J, Tirimanna P, van Weel C. Does the continuous use of bronchodilators mask the progression of asthma or chronic bronchitis? Fam Pract 1992; 9: 397-404.
129. 129. Braman S S, Kaemmerlen J T, Davis S M. Asthma in the elderly. A comparison between patients with recently acquired and long-standing disease. Am Rev Respir Dis 1991; 143: 336-340.
130. 130. Burrows B, Barbee R A, Cline M G, Knudson R J, Lebowitz M D. Characteristics of asthma among elderly adults in a sample of the general population. Chest 1991; 100: 935-942.
131. 131. Connolly M J, Crowley J J, Charan N B, Nielsen C P, Vestal R E. Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest 1995; 108: 401-406.
132. 132. Jaakkola M S, Jaakkola J J, Ernst P, Becklake M R. Respiratory symptoms in young adults should not be overlooked. Am Rev Respir Dis 1993; 147: 359-366.
133. 133. Vergnenegre A, Antonini M T, Bonnaud F, Melloni B, Mignonat G, Bousquet J. Comparison between late onset and childhood asthma. Allergol Immunopathol Madr 1992; 20: 190-196.
134. 134. Ulrik C S, Backer V, Dirksen A. Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow up. J Asthma 1992; 29: 29-38.
135. 135. Blanc P D, Jones M, Besson C, Katz P, Yelin E. Work disability among adults with asthma. Chest 1993; 104: 1371-1377.
136. 136. Dompeling E, van Schayck C P, Molema J, Folgering H, van Grunsven P M, van Weel C. Inhaled beclomethasone improves the course of asthma and COPD [see comments]. Eur Respir J 1992; 5: 945-952.
137. 137. Dompeling E, van Schayck C P, van Grunsven P M, van-Herwaarden C L, Akkermans R, Molema J, Folgering H, van-Weel C. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med 1993; 118: 770-778.
138. 138. van Essen-Zandvliet E E, Hughes M D, Waalkens H J, Duiverman E J, Pocock S J, Kerrebijn K F. Effects of 22 months of treatment with inhaled corticosteroids and/or β-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis 1992; 146: 547-554.
139. 1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group. Eur Respir J 1993; 6: 868-876.
140. 140. Cade J. Lung mechanics during provocation of asthma. Clin Sci 1971; 40: 381-386.
141. 141. Colebatch H, Finucane K, Smith M. Pulmonary conductance and elastic recoid in asthma and emphysema. J Appl Physiol 1973; 34: 143-153.
142. 142. McCarthy D S, Sigurdson M. Lung elastic recoil and reduced airflow in clinically stable asthma. Thorax 1980; 35: 298-302.
143. 143. Woolcock A, Read J. The static elastic properties of the lung in asthma. Am Rev Respir Dis 1968; 98: 298-302.
144. 144. Zapletal A, Desmond K J, Demizio D, Coates A L. Lung recoid and the determination of airflow limitation in cystic fibrosis and asthma. Pediatr Pulmonol 1993; 15: 13-18.
145. 145. Neeld D A, Goodman L R, Gurney J W, Greenberger P A, Fink J N. Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1990; 142: 1200-1205.
146. 146. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373-381.
147. 147. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijarvi A. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331: 700-705.
148. 148. Selroos O, Pietinalho A, Lofroos A B, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma [see comments]. Chest 1995; 108: 1228-1234.